首页> 外国专利> STABILIZED LYOPHILIZED COMPOSITIONS COMPRISING TISSUE FACTOR PATHWAY INHIBITOR OR TISSUE FACTOR PATHWAY INHIBITOR VARIANTS

STABILIZED LYOPHILIZED COMPOSITIONS COMPRISING TISSUE FACTOR PATHWAY INHIBITOR OR TISSUE FACTOR PATHWAY INHIBITOR VARIANTS

机译:包含组织因子途径抑制剂或组织因子途径抑制剂变体的稳定的脂质体组合物

摘要

Lyophilized compositions of TFPI or a TFPI variant suitable for long-term storage can be formed by lyophilizing an aqueous formulation of the TFPI or TFPI variant having a pH from about 4 to about 8 with a carbohydrate or amino acid glass forming agent. These lyophilized compositions are stable for greater than three months when stored at 40° C.
机译:适于长期保存的TFPI或TFPI变体的冻干组合物可以通过用碳水化合物或氨基酸玻璃形成剂冻干pH为约4至约8的TFPI或TFPI变体的水性制剂来形成。这些冻干的组合物在40℃下储存时稳定超过三个月。

著录项

  • 公开/公告号PT1589949E

    专利类型

  • 公开/公告日2008-11-06

    原文格式PDF

  • 申请/专利权人 NOVARTIS VACCINES AND DIAGNOSTICS INC.;

    申请/专利号PT20040700827T

  • 发明设计人 BAO-LU CHEN;MANINDER HORA;

    申请日2004-01-08

  • 分类号A61K9/19;A61K31/715;A61K38/17;A61K38/57;A61K47/18;A61K47/26;

  • 国家 PT

  • 入库时间 2022-08-21 20:06:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号